ENDONOVO THERAPEUTICS INC | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
ENDONOVO THERAPEUTICS INC | 8-K: Current report
ENDONOVO THERAPEUTICS INC | 10-Q/A: Quarterly report (Amendment)
ENDONOVO THERAPEUTICS INC | 10-Q: Q3 2023 Earnings Report
ENDONOVO THERAPEUTICS INC | 8-K: Current report
ENDONOVO THERAPEUTICS INC | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
ENDONOVO THERAPEUTICS INC | 8-K: Current report
ENDONOVO THERAPEUTICS INC | 1-A/A: Others
ENDONOVO THERAPEUTICS INC | 10-Q: Q2 2023 Earnings Report
ENDONOVO THERAPEUTICS INC | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
ENDONOVO THERAPEUTICS INC | 1-A/A: Others
ENDONOVO THERAPEUTICS INC | 10-Q: Q1 2023 Earnings Report
ENDONOVO THERAPEUTICS INC | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
ENDONOVO THERAPEUTICS INC | 10-K: FY2022 Annual Report
ENDONOVO THERAPEUTICS INC | NT 10-K: Others
ENDONOVO THERAPEUTICS INC | 8-K: Current report
ENDONOVO THERAPEUTICS INC | 10-Q: Q3 2022 Earnings Report
ENDONOVO THERAPEUTICS INC | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
ENDONOVO THERAPEUTICS INC | 8-K: Current report
ENDONOVO THERAPEUTICS INC | 10-Q: Q2 2022 Earnings Report
No Data